Published 9 days ago • loading... • Updated 9 days ago

CathWorks Announces Key Events for EuroPCR 2025

CathWorks announced key events for EuroPCR 2025, scheduled May 20 to 23 at the Palais des Congrès in Paris, France.
This announcement comes after investigators at TCT 2024 in Washington, DC, reported that the PROVISION Study successfully achieved its primary endpoint, demonstrating the advantages of FFRangio.
EuroPCR events will include Dr. Toru Tanigaki presenting one-year PROVISION1 Study results comparing FFRangio to invasive FFR guidance.
CathWorks CEO Ramin Mousavi expressed enthusiasm about strengthening collaborations within the interventional cardiology field to establish FFRangio as the global benchmark for patient care.
The events and partnerships, including with Medtronic, highlight expanding adoption of CathWorks FFRangio, a non-invasive system integrated in hundreds of catheterization labs worldwide.

Insights by Ground AI

Does this summary seem wrong?

13 Articles

All

Left

Center

Right

Aspen Daily News

+12 Reposted by 12 other sources

Center

CathWorks Announces Key Events for EuroPCR 2025

NEWPORT BEACH, Calif. and AMSTERDAM, May 16, 2025 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming EuroPCR 2025 conference taking place May 20 to 23…

9 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year